Gentamicin Injection, Solution
Product Images NDC 0404-9866

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gentamicin (NDC 0404-9866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is a description for Gentamicin, an injection used for intramuscular or intravenous use only. The container must be diluted before use. The closure is not made with natural rubber latex, and it must be kept out of children's reach. The injection should be stored at a temperature between 20-25ÂșC, and patients treated with Gentamicin Sulfate and other aminoglycosides should be under close clinical observation due to potential toxicity. The manufacturer is Fresenius Kabi, and the package contains 20 ml of the injection in a multiple-dose vial. The lot number is XK-XXX-XX, and the NDC is 63323-010-20. There's also information for reserving and the expiration date, but there's not enough information to indicate those.*
FDA Label Image

Table1.jpg (Table1)

Table1.jpg (Table1)
Table 1: Susceptibility Interpretive Criteria for Gentamicin provides information on the recommended minimal inhibitory concentration (MIC) and zone diameter for different pathogens. Susceptibility interpretive criteria are provided for Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus Species.*
FDA Label Image

Table2.jpg (Table2)

Table2.jpg (Table2)
This is a table displaying the acceptable quality control ranges for Gentamicin. It includes the minimum inhibitory concentrations and zone diameter in mm for various organisms including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococeus faecalis. There is also a note suggesting to refer to Table 31 for control organisms for high-level aminoglycoside screen tests for enterococci.*
FDA Label Image

Table3.jpg (Table3)

FDA Label Image

Table4.jpg (Table4)

FDA Label Image

Table5.jpg (Table5)

Table5.jpg (Table5)
This is a list of product codes, units of sale, and strength for a medication available in two different sizes (2mL and 20mL) at two different strengths (80mg per 2mL and 800mg per 20mL). The medication is sold in multiple dose vials and the unit of sale is a packet of 25 vials per NDC code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.